Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach

Tekijä Hu, Xiao, Liu, Xikui, Morgan, Rodney, Moisan, Jacques, Hao, Ling-Yang, Wang, Yahong, Sanchez, Brian, Lesch, Charles, Bousley, Dick, Taylor, Clark, Aicher, Thomas, Toogood, Peter, Zou, Weiping, Glick, Gary, Carter, Laura
Julkaisussa J Immunother Cancer (2014)

Anaplerotic Metabolism of Alloreactive T Cells Provides a Metabolic Approach To Treat Graft-Versus-Host Disease

Tekijä Glick, Gary D., Rossignol, Rodrigue, Lyssiotis, Costas A., Wahl, Daniel, Lesch, Charles, Sanchez, Brian, Liu, Xikui, Hao, Ling-Yang, Taylor, Clarke, Hurd, Alexander, Ferrara, James L. M., Tkachev, Victor, Byersdorfer, Craig A., Boros, Laszlo, Opipari, Anthony W.
Julkaistu 2014

RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity

Tekijä Hu, Xiao, Moisan, Jacques, Majchrzak, Kinga, Lesch, Chuck, Wang, Yahong, Sanchez, Brian, Liu, Xikui, Morgan, Rodney, Mertz, David, Bousley, Dick, van Huis, Chad, Skalitzky, Don, Taylor, Clarke, Aicher, Thomas, Toogood, Peter, Zou, Weiping, Glick, Gary, Paulos, Chrystal, Carter, Laura
Julkaisussa J Immunother Cancer (2015)

Inhibiting Oxidative Phosphorylation in Vivo Restrains T(H)17 Effector Responses and Ameliorates Murine Colitis()

Tekijä Franchi, Luigi, Monteleone, Ivan, Hao, Ling-Yang, Spahr, Mark, Zhao, Wenpu, Liu, Xikui, Demock, Kellie, Kulkarni, Aditi, Lesch, Chuck A., Sanchez, Brian, Carter, Laura, Marafini, Irene, Hu, Xiao, Mashadova, Oksana, Yuan, Min, Asara, John M., Singh, Harinder, Lyssiotis, Costas A., Monteleone, Giovanni, Opipari, Anthony W., Glick, Gary D.
Julkaisussa J Immunol (2017)